Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2627108 | 1.00 | DPP4 (0.33) | DPP4 | |
| SCHEMBL24994972 | 1.00 | DPP4 (0.33) | DPP4 | |
| SCHEMBL23139737 | 0.78 | — | — | |
| SCHEMBL14560944 | 0.77 | — | — | |
| SCHEMBL15425574 | 0.75 | — | — | |
| SCHEMBL2627099 | 0.75 | FDPS (0.31) | — | |
| SCHEMBL18197848 | 0.75 | FDPS (0.31) | — | |
| SCHEMBL18880028 | 0.75 | DPP4 (0.31) | DPP4 | |
| SCHEMBL12961609 | 0.73 | DPP4 (0.30) | DPP4 | |
| SCHEMBL14050397 | 0.73 | TSHR (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016940-A1 | LONG-ACTING AND LONG-CIRCULATING DELIVERY VEHICLES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-01-18 | — | — | US | disclosed |
| EP-3950918-A1 | CELL CULTURE SCAFFOLD MATERIAL, CELL CULTURE VESSEL, CELL CULTURE FIBER AND METHOD FOR CULTURING CELL | SEKISUI CHEMICAL CO., LTD. (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-11071693-B2 | Direct dental filling composition | DENTSPLY SIRONA INC. (US) | 2021-07-27 | — | — | US | disclosed |
| WO-2021055759-A1 | SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE | GLYSCEND, INC. (US) | 2021-03-25 | — | — | WO | disclosed |
| WO-2021055752-A1 | BENZOXABOROLE POLYMERS AND METHODS OF USE | GLYSCEND, INC. (US) | 2021-03-25 | — | — | WO | disclosed |
| US-20210063888-A1 | METHOD FOR FORMING PATTERNED PHOTORESIST | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-03-04 | — | — | US | disclosed |
| EP-3235836-B1 | POLYMER | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| WO-2020203769-A1 | CELL CULTURE SCAFFOLD MATERIAL, CELL CULTURE VESSEL, CELL CULTURE FIBER AND METHOD FOR CULTURING CELL | 積水化学工業株式会社 | 2020-10-08 | — | — | WO | disclosed |
| WO-2020203770-A1 | CELL CULTURE SCAFFOLD MATERIAL, CELL CULTURE VESSEL, CELL CULTURE CARRIER, CELL CULTURE FIBER AND CELL CULTURE METHOD | 積水化学工業株式会社 | 2020-10-08 | — | — | WO | disclosed |
| US-10781218-B2 | Substituted inhibitors of menin-MLL and methods of use | KURA ONCOLOGY, INC. (US) | 2020-09-22 | — | — | US | disclosed |
| US-20120067209-A1 | GAS SEPARATION MEMBRANE | NTNU TECHNOLOGY TRANSFER AS (NO) | 2012-03-22 | — | — | US | disclosed |
| US-20110287262-A1 | NANOPARTICLES, NANOCAPSULES AND NANOGELS | UNIVERSITY OF KANSAS | 2011-11-24 | — | — | US | disclosed |
| US-20110100830-A1 | CHEMICAL CONVERSION TREATMENT SOLUTION FOR A STEEL MATERIAL AND CHEMICAL CONVERSION TREATMENT METHOD | HENKEL AG & CO., KGAA (DE) | 2011-05-05 | — | — | US | disclosed |
| US-20100316589-A1 | Coated Pharmaceutical Compositions | GENZYME CORPORATION | 2010-12-16 | — | — | US | disclosed |
| US-20090226392-A1 | Phosphate-Binding Polymers for Oral Administration | GELTEX, INC. | 2009-09-10 | — | — | US | disclosed |
| EP-1765907-B1 | CURABLE COMPOSITIONS WITH AN IMPROVED ADHESION PERFORMANCE | HENKEL AG & CO KGAA (DE) | 2009-08-26 | — | — | EP | disclosed |
| EP-2067882-A1 | METHOD OF TREATING SURFACE OF METAL BASE, METALLIC MATERIAL TREATED BY THE SURFACE TREATMENT METHOD, AND METHOD OF COATING THE METALLIC MATERIAL | Nippon Paint Co., Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
| US-7459151-B2 | Phosphate-binding polymers for oral administration | GENZYME CORPORATION (US) | 2008-12-02 | — | — | US | disclosed |
| US-20080179188-A1 | METHODS, COMPOSITIONS AND DEVICES, INCLUDING ELECTROOSMOTIC PUMPS, COMPRISING COATED POROUS SURFACES | EKSIGENT TECHNOLOGIES, INC. (US) | 2008-07-31 | — | — | US | disclosed |
| EP-1923363-A2 | Hydrophilic member and substrate for hydrophilic member | FUJIFILM Corporation (JP) | 2008-05-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090226392-A1 | Phosphate-Binding Polymers for Oral Administration | PHPT1, SLC34A2, ALPI | DPP4 685/4885 |
| US-20240016940-A1 | LONG-ACTING AND LONG-CIRCULATING DELIVERY VEHICLES | VEGFA, LDLR, LIPG | DPP4 3384/4885 |
| US-20110287262-A1 | NANOPARTICLES, NANOCAPSULES AND NANOGELS | KCNA6, CD44, KCNA5 | DPP4 3111/4885 |
| US-20100316589-A1 | Coated Pharmaceutical Compositions | SLC20A2, PHOSPHO1, SLC20A1 | DPP4 2020/4885 |
| US-10781218-B2 | Substituted inhibitors of menin-MLL and methods of use | MLLT1, MEN1, MLLT3 | DPP4 3904/4885 |
| US-11071693-B2 | Direct dental filling composition | CAD, DOCK5, ITGA5 | DPP4 3913/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.